BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25804235)

  • 21. The analogy in cell immunophenotype and parameters of cell cycle of ectopic thymus, normal thymus, and some acute lymphoblastic leukemia of T-phenotype.
    Babusíková O; Tomová A
    Neoplasma; 2002; 49(5):312-8. PubMed ID: 12458329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression pattern of hybrid phenotype in adult acute lymphoblastic leukemia.
    Nakase K; Kita K; Miwa H; Nishii K; Shiku H; Nasu K; Dohy H; Kyo T; Kamada N; Tsutani H
    Cancer Detect Prev; 2001; 25(4):394-405. PubMed ID: 11531016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunophenotyping of acute lymphatic leukemia: diagnostic aspects and clinical relevance].
    Ludwig WD; Reiter A; Schott G; Schwartz S; Thiel E
    Wien Klin Wochenschr; 1994; 106(8):231-2, 233-7. PubMed ID: 8023515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
    Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells.
    Gaipa G; Coustan-Smith E; Todisco E; Maglia O; Biondi A; Campana D
    Haematologica; 2002 Apr; 87(4):347-56. PubMed ID: 11940478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia.
    Drexler HG; Thiel E; Ludwig WD
    Leukemia; 1991 Aug; 5(8):637-45. PubMed ID: 1886419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunophenotypic, cytogenetic, and clinical features of 207 cases of childhood acute lymphoblastic leukemia in china.
    Tong H; Wang Q; Lu C; Liu Z; Hu Y
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):437-41. PubMed ID: 21792039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunophenotypic aberrancies in acute lymphoblastic leukemia from 282 Iraqi patients.
    Jalal SD; Al-Allawi NAS; Al Doski AAS
    Int J Lab Hematol; 2017 Dec; 39(6):625-632. PubMed ID: 28722319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies].
    Ludwig WD; Teichmann JV; Sperling C; Komischke B; Ritter J; Reiter A; Odenwald E; Sauter S; Riehm H
    Klin Padiatr; 1990; 202(4):243-52. PubMed ID: 2203938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunophenotyping and its clinical significance in childhood acute lymphoblastic leukemia].
    Zhang YD; Tan LN; Hu Q; Wei HY; Zhang XL; Xiong H
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Mar; 14(3):188-91. PubMed ID: 22433405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of some cytochemical activities to the expression of CD34 marker in acute leukemia.
    Klobusická M; Babusíková O; Hrivnáková A
    Neoplasma; 1993; 40(5):309-14. PubMed ID: 7505888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
    Klobusická M; Babusíková O
    Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of immunophenotype of B-lineage acute lymphoblastic leukemia cells by 4-color flow cytometry].
    Wang H; Liu YR; Chen SS; Chang Y; Qin YZ; Li JL; Fu JY; Ruan GR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):137-41. PubMed ID: 12744734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination.
    Thalhammer-Scherrer R; Mitterbauer G; Simonitsch I; Jaeger U; Lechner K; Schneider B; Fonatsch C; Schwarzinger I
    Am J Clin Pathol; 2002 Mar; 117(3):380-9. PubMed ID: 11888077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Phenotypic changes in refractory and relapse acute lymphoblastic leukemias].
    Gómez E; San Miguel JF; González M; Orfao A; Cañizo MC; Ciudad J; López Borrasca A
    Sangre (Barc); 1991 Jun; 36(3):201-4. PubMed ID: 1948539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunophenotyping characteristics of T-cell acute lymphoblastic leukemia].
    Chen LJ; Li JY; Wu YJ; Yang H; Qian SX; Wu HX; Lu H; Xu W; Sheng RL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):692-5. PubMed ID: 17708784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.